Cat.#: ACPP-1218
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1445 | Human RAB4A Protein (AC1445) | 2 µg | inquiry |
| ACPP-1767 | Human YIF1B Protein (AC1767) | 5 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1078 | Glutamate Receptor 1 Blocking Peptide (AC1078) | 250 µg | inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1053 | Recombinant Mouse CD24 Protein (Fc Tag) (AC1053) | 50 µg | inquiry |
| ACPP-1478 | Human IL 6 Protein, His (AC1478) | 10 µg | inquiry |
| ACPP-1560 | Human RBM17 Protein (AC1560) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.